TrialHaematologica2023
Randomized phase II study of weekly carfilzomib 70 mg/m
Borja Puertas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled ittrialcites it
TrialHaematologica2023
Borja Puertas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.